Who is seeking antiretroviral treatment for HIV now? Characteristics of patients presenting in Kenya and South Africa in 2017‐2018

Author:

Brennan Alana T123,Maskew Mhairi3,Larson Bruce A1ORCID,Tsikhutsu Isaac45,Bii Margaret45,Vezi Lungisile3,Fox Matthew P123,Venter Willem DF6,Ehrenkranz Peter7ORCID,Rosen Sydney13

Affiliation:

1. Department of Global Health Boston University School of Public Health Boston MA USA

2. Department of Epidemiology Boston University School of Public Health Boston MA USA

3. Health Economics and Epidemiology Research Office Department of Internal Medicine School of Clinical Medicine Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

4. Kenya Medical Research Institute/U.S. Army Medical Research Directorate‐Africa Nairobi Kenya

5. Henry Jackson Foundation MRI Kericho Kenya

6. Wits Reproductive Health and HIV Institute Department of Internal Medicine School of Clinical Medicine Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

7. Bill and Melinda Gates Foundation Seattle WA USA

Funder

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference15 articles.

1. World Health Organization.Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.2016.

2. WHO(World Health Organization).Fact Sheet: WHO HIV Policy Adoption and Implementation Status in Countries.2018:1–4.

3. WHO(World Health Organization).Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach.2013.

4. Simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE): protocol for a randomised evaluation

5. Improved simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE II): protocol for a randomized evaluation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3